See more : Fusic Co., Ltd. (5256.T) Income Statement Analysis – Financial Results
Complete financial analysis of Hologic, Inc. (HOLX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hologic, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Beijing Jingwei Hirain Technologies Co., Inc. (688326.SS) Income Statement Analysis – Financial Results
- Lingotes Especiales, S.A. (LGT.MC) Income Statement Analysis – Financial Results
- Zhejiang Zhaolong Interconnect Technology Co., Limited (300913.SZ) Income Statement Analysis – Financial Results
- Jiangsu Jiangnan High Polymer Fiber Co.,Ltd (600527.SS) Income Statement Analysis – Financial Results
- NEXON Co., Ltd. (NEXOY) Income Statement Analysis – Financial Results
Hologic, Inc. (HOLX)
About Hologic, Inc.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.03B | 4.03B | 4.86B | 5.63B | 3.78B | 3.37B | 3.22B | 3.06B | 2.83B | 2.71B | 2.53B | 2.49B | 2.00B | 1.79B | 1.68B | 1.64B | 1.67B | 738.37M | 462.68M | 287.68M | 228.71M | 204.04M | 190.19M | 178.49M | 93.75M | 84.10M | 115.60M | 106.70M | 88.20M | 43.40M | 38.50M | 24.80M | 26.20M | 17.10M | 19.80M | 11.40M |
| Cost of Revenue | 1.80B | 1.96B | 1.87B | 1.84B | 1.55B | 2.06B | 1.52B | 1.44B | 1.27B | 1.27B | 1.29B | 1.33B | 1.01B | 866.17M | 942.91M | 779.65M | 781.98M | 392.80M | 269.15M | 174.66M | 143.34M | 130.46M | 118.38M | 116.18M | 59.18M | 46.80M | 54.00M | 46.20M | 40.40M | 21.50M | 20.30M | 13.30M | 13.20M | 8.20M | 9.20M | 4.10M |
| Gross Profit | 2.23B | 2.07B | 3.00B | 3.80B | 2.23B | 1.31B | 1.70B | 1.62B | 1.56B | 1.43B | 1.25B | 1.16B | 994.44M | 923.18M | 736.64M | 857.49M | 892.52M | 345.57M | 193.53M | 113.03M | 85.37M | 73.58M | 71.82M | 62.31M | 34.56M | 37.30M | 61.60M | 60.50M | 47.80M | 21.90M | 18.20M | 11.50M | 13.00M | 8.90M | 10.60M | 7.30M |
| Gross Profit Ratio | 55.28% | 51.40% | 61.64% | 67.39% | 58.98% | 38.85% | 52.73% | 52.99% | 55.19% | 52.96% | 49.22% | 46.60% | 49.66% | 51.59% | 43.86% | 52.38% | 53.30% | 46.80% | 41.83% | 39.29% | 37.33% | 36.06% | 37.76% | 34.91% | 36.87% | 44.35% | 53.29% | 56.70% | 54.20% | 50.46% | 47.27% | 46.37% | 49.62% | 52.05% | 53.54% | 64.04% |
| Research & Development | 272.80M | 294.30M | 283.40M | 276.30M | 222.50M | 232.20M | 218.70M | 232.80M | 232.10M | 214.90M | 203.20M | 197.65M | 130.96M | 116.70M | 104.31M | 94.33M | 81.42M | 44.48M | 28.29M | 18.62M | 16.66M | 18.38M | 20.36M | 23.33M | 17.18M | 12.70M | 9.80M | 8.50M | 7.30M | 4.30M | 3.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 409.40M | 392.40M | 407.70M | 433.20M | 356.00M | 332.30M | 366.10M | 343.30M | 267.30M | 261.00M | 259.80M | 227.68M | 220.04M | 158.79M | 159.74M | 148.83M | 147.41M | 0.00 | 42.55M | 27.58M | 24.36M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 585.40M | 595.20M | 630.30M | 561.20M | 484.60M | 564.90M | 544.60M | 498.60M | 415.10M | 363.00M | 331.70M | 342.14M | 322.31M | 286.73M | 247.37M | 238.98M | 261.52M | 0.00 | 55.91M | 34.20M | 31.76M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 994.80M | 987.60M | 1.04B | 994.40M | 840.60M | 897.20M | 910.70M | 841.90M | 682.40M | 624.00M | 591.50M | 569.82M | 542.36M | 445.52M | 407.12M | 387.80M | 408.93M | 147.75M | 98.46M | 61.78M | 56.12M | 52.17M | 47.23M | 56.27M | 40.32M | 30.70M | 39.10M | 28.30M | 34.80M | 12.30M | 10.10M | 13.10M | 11.40M | 8.40M | 7.20M | 5.50M |
| Other Expenses | 77.60M | -1.70M | 45.20M | 42.20M | 39.70M | 52.00M | 7.60M | 12.90M | 26.60M | -11.00M | -3.60M | 3.61M | 7.26M | -4.18M | 901.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.35B | 1.31B | 1.37B | 1.31B | 1.10B | 1.18B | 1.19B | 1.14B | 1.00B | 949.10M | 908.50M | 880.06M | 745.81M | 536.05M | 566.28M | 533.34M | 518.48M | 197.82M | 123.29M | 80.39M | 72.78M | 70.56M | 67.59M | 79.60M | 61.92M | 46.90M | 50.80M | 38.10M | 35.70M | 17.20M | 14.10M | 13.50M | 11.70M | 8.70M | 7.40M | 5.60M |
| Cost & Expenses | 3.15B | 3.27B | 3.23B | 3.15B | 2.65B | 3.24B | 2.71B | 2.58B | 2.27B | 2.22B | 2.19B | 2.21B | 1.75B | 1.40B | 1.51B | 1.31B | 1.30B | 590.62M | 392.44M | 255.05M | 216.12M | 201.01M | 185.97M | 195.78M | 121.11M | 93.70M | 104.80M | 84.30M | 76.10M | 38.70M | 34.40M | 26.80M | 24.90M | 16.90M | 16.60M | 9.70M |
| Interest Income | 108.70M | 120.50M | 12.90M | 1.40M | 4.30M | 4.60M | 6.30M | 3.80M | 700.00K | 1.30M | 1.30M | 1.30M | 2.34M | 1.86M | 1.28M | 1.16M | 4.53M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 122.10M | 111.10M | 95.10M | 93.60M | 116.50M | 140.80M | 148.70M | 153.20M | 155.30M | 205.50M | 220.60M | 281.08M | 140.29M | 114.85M | 126.21M | 73.16M | 84.91M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 309.00M | 323.40M | 430.10M | 406.90M | 376.00M | 463.00M | 480.30M | 449.20M | 465.40M | 491.40M | 113.80M | 112.60M | 72.04M | 58.33M | 54.86M | 51.21M | 172.95M | 31.16M | 16.13M | 7.57M | 7.59M | 7.41M | 7.48M | 8.74M | 4.42M | 3.50M | 1.90M | 1.30M | 900.00K | 600.00K | 600.00K | 400.00K | 300.00K | 300.00K | 200.00K | 100.00K |
| EBITDA | 1.30B | 1.11B | 2.11B | 2.86B | 1.50B | 346.10M | 210.40M | 1.83B | 1.04B | 874.10M | 791.90M | -395.88M | 424.40M | 646.97M | 366.88M | -1.75B | -21.28M | 178.91M | 70.55M | 40.21M | 20.18M | 3.03M | 11.70M | -8.55M | -22.94M | -6.10M | 12.70M | 23.70M | 18.30M | 5.30M | 4.70M | -1.60M | 1.60M | 500.00K | 3.40M | 1.80M |
| EBITDA Ratio | 32.16% | 29.87% | 43.28% | 51.24% | 40.09% | 17.74% | 31.14% | 31.05% | 37.13% | 35.69% | 17.67% | 15.95% | 16.37% | 27.40% | 13.49% | 23.00% | 67.05% | 24.23% | 21.87% | 13.98% | 8.82% | 5.11% | 7.24% | -3.94% | -18.89% | -6.66% | 6.40% | 17.34% | 9.18% | 17.28% | 11.69% | -7.66% | 3.05% | -1.75% | 14.14% | 14.91% |
| Operating Income | 882.60M | 668.40M | 1.64B | 2.48B | 1.11B | 134.40M | -237.90M | 1.37B | 548.60M | 455.10M | 279.70M | -906.28M | 113.72M | 374.45M | 69.94M | -2.02B | -197.54M | 147.75M | 50.34M | 32.63M | 12.59M | 3.03M | 2.16M | -18.81M | -27.36M | -9.60M | 10.80M | 22.40M | 12.10M | 4.70M | 4.10M | -2.00M | 1.30M | 200.00K | 3.20M | 1.70M |
| Operating Income Ratio | 21.90% | 16.58% | 33.73% | 44.04% | 29.26% | 3.99% | -7.39% | 44.80% | 19.37% | 16.82% | 11.05% | -36.36% | 5.68% | 20.93% | 4.16% | -123.18% | -11.80% | 20.01% | 10.88% | 11.34% | 5.50% | 1.48% | 1.13% | -10.54% | -29.18% | -11.41% | 9.34% | 20.99% | 13.72% | 10.83% | 10.65% | -8.06% | 4.96% | 1.17% | 16.16% | 14.91% |
| Total Other Income/Expenses | -17.50M | 7.70M | -52.00M | -119.20M | -103.10M | -296.30M | -180.70M | -139.70M | -133.30M | -277.90M | -231.60M | -286.68M | -175.36M | -147.06M | -124.93M | -72.00M | -81.60M | 737.00K | -11.92M | 2.06M | 341.00K | 240.00K | -2.41M | -1.88M | -1.66M | 3.80M | 5.40M | 5.10M | -300.00K | -2.10M | 200.00K | -100.00K | 800.00K | 800.00K | 500.00K | 0.00 |
| Income Before Tax | 865.10M | 676.10M | 1.59B | 2.36B | 1.00B | -95.30M | -418.60M | 1.23B | 415.30M | 177.20M | 48.10M | -1.19B | -61.66M | 227.39M | -54.99M | -2.09B | -279.14M | 148.49M | 53.22M | 34.70M | 12.93M | 3.27M | -250.00K | -20.68M | -29.02M | -5.80M | 16.20M | 27.50M | 17.10M | 2.60M | 4.30M | -2.10M | 2.10M | 1.00M | 3.70M | 1.70M |
| Income Before Tax Ratio | 21.46% | 16.78% | 32.66% | 41.92% | 26.53% | -2.83% | -13.01% | 40.23% | 14.66% | 6.55% | 1.90% | -47.87% | -3.08% | 12.71% | -3.27% | -127.58% | -16.67% | 20.11% | 11.50% | 12.06% | 5.65% | 1.60% | -0.13% | -11.59% | -30.95% | -6.90% | 14.01% | 25.77% | 19.39% | 5.99% | 11.17% | -8.47% | 8.02% | 5.85% | 18.69% | 14.91% |
| Income Tax Expense | 75.60M | 220.10M | 286.20M | 491.40M | -108.60M | -55.10M | -307.30M | 475.00M | 84.50M | 45.60M | 30.80M | -20.12M | 11.97M | 70.24M | 7.82M | 87.56M | 106.48M | 53.91M | 25.80M | 6.44M | 763.00K | 176.00K | -429.00K | 169.00K | -10.40M | -2.10M | 5.80M | 9.80M | 5.70M | 700.00K | 1.30M | -300.00K | 600.00K | 300.00K | 1.10M | 300.00K |
| Net Income | 789.50M | 456.00M | 1.30B | 1.87B | 1.12B | -40.20M | -111.30M | 755.50M | 330.80M | 131.60M | 17.30M | -1.17B | -73.63M | 157.15M | -62.81M | -2.18B | -385.62M | 94.58M | 27.42M | 28.26M | 12.16M | 2.88M | 179.00K | -20.85M | -18.62M | -3.70M | 10.40M | 17.70M | 11.40M | 1.90M | 3.00M | -1.80M | 1.50M | 700.00K | 2.60M | 1.40M |
| Net Income Ratio | 19.59% | 11.31% | 26.77% | 33.23% | 29.53% | -1.19% | -3.46% | 24.70% | 11.68% | 4.87% | 0.68% | -47.06% | -3.68% | 8.78% | -3.74% | -132.93% | -23.03% | 12.81% | 5.93% | 9.82% | 5.32% | 1.41% | 0.09% | -11.68% | -19.86% | -4.40% | 9.00% | 16.59% | 12.93% | 4.38% | 7.79% | -7.26% | 5.73% | 4.09% | 13.13% | 12.28% |
| EPS | 3.35 | 1.85 | 5.18 | 7.28 | 4.24 | -0.15 | -0.40 | 2.70 | 1.18 | 0.47 | 0.06 | -4.36 | -0.28 | 0.60 | -0.24 | -8.48 | -1.57 | 0.88 | 0.30 | 0.33 | 0.15 | 0.04 | 0.00 | -0.34 | -0.30 | -0.07 | 0.20 | 0.34 | 0.24 | 0.05 | 0.12 | -0.06 | 0.05 | 0.02 | 0.09 | 0.07 |
| EPS Diluted | 3.32 | 1.83 | 5.13 | 7.21 | 4.21 | -0.15 | -0.40 | 2.64 | 1.16 | 0.45 | 0.06 | -4.36 | -0.28 | 0.59 | -0.24 | -8.48 | -1.57 | 0.86 | 0.28 | 0.32 | 0.14 | 0.04 | 0.00 | -0.34 | -0.30 | -0.07 | 0.19 | 0.33 | 0.23 | 0.05 | 0.12 | -0.06 | 0.05 | 0.02 | 0.09 | 0.06 |
| Weighted Avg Shares Out | 235.72M | 246.77M | 251.53M | 257.05M | 262.73M | 269.41M | 275.11M | 279.81M | 280.21M | 280.57M | 275.50M | 268.70M | 262.86M | 261.10M | 258.74M | 256.55M | 245.97M | 106.87M | 93.02M | 85.65M | 81.03M | 78.52M | 73.68M | 61.90M | 61.28M | 56.92M | 53.33M | 51.68M | 47.01M | 35.01M | 24.49M | 31.30M | 31.58M | 31.11M | 28.11M | 8.71M |
| Weighted Avg Shares Out (Dil) | 237.55M | 248.83M | 253.85M | 259.71M | 264.61M | 269.41M | 275.11M | 285.65M | 286.16M | 289.54M | 278.36M | 268.70M | 264.04M | 264.31M | 258.74M | 256.55M | 245.97M | 109.67M | 97.24M | 90.25M | 85.19M | 80.52M | 76.77M | 61.90M | 61.28M | 56.92M | 55.47M | 54.46M | 50.11M | 36.60M | 24.49M | 31.30M | 31.58M | 31.11M | 28.11M | 8.71M |
HOLX Stock Set to Gain From New Study Data on Genius AI Detection 2.0
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
Hologic Presents New Research Demonstrating How Its Breast Imaging AI Solution Performs Similarly Across Diverse Populations
Hologic to Debut AI-Powered Innovations at RSNA 2024: Stock to Gain?
Hologic Invites Attendees to Step Into the Future of Breast Health and AI at RSNA 2024
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
Should You Retain Hologic Stock in Your Portfolio Now?
Hologic to Webcast Presentations at Upcoming Investor Conferences
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Hologic Post Q4 Earnings Miss: Time to Buy, Hold or Sell the Stock?
Source: https://incomestatements.info
Category: Stock Reports